Excedrin Tablet, Film Coated
NDC Package 67751-243-02

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Excedrin (acetaminophen, aspirin, and caffeine) tablets is a medication a combination of aspirin, acetaminophen, and caffeine. This formulation utilizes a tablet, film coated delivery system. Marketed by Navajo Manufacturing Company Inc., this product is identified by NDC 67751-243 and is authorized under FDA application NDA020802.

Identification & Billing

NDC Package Code
67751-243-02
Package Description
2 POUCH in 1 CARTON / 2 TABLET, FILM COATED in 1 POUCH
Product Code
11-Digit Billing Format
67751024302
RxNorm Crosswalk
  • RxCUI: 209468 - EXCEDRIN 250 MG / 250 MG / 65 MG Oral Tablet
  • RxCUI: 209468 - acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet [Excedrin]
  • RxCUI: 209468 - APAP 250 MG / ASA 250 MG / Caffeine 65 MG Oral Tablet [Excedrin]
  • RxCUI: 209468 - Excedrin Extra Strength (APAP 250 MG / ASA 250 MG / caffeine 65 MG) Oral Tablet
  • RxCUI: 209468 - Excedrin Menstrual Complete (APAP 250 MG / ASA 250 MG / caffeine 65 MG) Oral Tablet

Clinical Specifications

Proprietary Name
Excedrin Migraine
Non-Proprietary Name
Acetaminophen, Aspirin, And Caffeine
Substance Name
Acetaminophen; Aspirin; Caffeine
Dosage Form
Tablet, Film Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer.
Administration Route
Oral - Administration to or by way of the mouth.
Usage Information
This product is a combination of aspirin, acetaminophen, and caffeine. It is used for the temporary relief of pain from conditions such as muscle aches, toothaches, menstrual cramps, or headaches (including migraine). Aspirin and acetaminophen relieve pain by keeping your body from making certain natural substances. Caffeine helps increase the effects of aspirin and acetaminophen.

Regulatory & Marketing

Labeler Name
Navajo Manufacturing Company Inc.
Product Type
Human Otc Drug
FDA Application #
NDA020802
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
03-13-2025
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 67751-243-02 identifies a specific commercial package of 2 pouch in 1 carton / 2 tablet, film coated in 1 pouch of Excedrin Migraine, a human over the counter drug labeled by Navajo Manufacturing Company Inc.. This tablet, film coated is formulated for oral use and contains acetaminophen; aspirin; caffeine as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Navajo Manufacturing Company Inc. on March 13, 2025. The current certification is valid through December 31, 2027.

What are the primary indications for this medication?

This product is a combination of aspirin, acetaminophen, and caffeine. It is used for the temporary relief of pain from conditions such as muscle aches, toothaches, menstrual cramps, or headaches (including migraine). Aspirin and acetaminophen relieve pain by keeping your body from making certain natural substances. Caffeine helps increase the effects of aspirin and acetaminophen.

How is this Navajo Manufacturing Company Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 67751024302. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
67751-243-02
11-Digit CMS (5-4-2)
67751-0243-02

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.